Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
News Medical on MSN7h
Neoantigen vaccine sparks powerful immune defense against kidney cancerA personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
The ideal indication for NSS in the presence of a normal contralateral kidney is, therefore, the presence of an easily resectable, small (4 cm diameter or less), solitary, exophytic renal tumor ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback